MLTX logo

MoonLake Immunotherapeutics (MLTX) Current Assets

Annual Current Assets:

$474.29M-$39.88M(-7.76%)
December 31, 2024

Summary

  • As of today, MLTX annual total current assets is $474.29 million, with the most recent change of -$39.88 million (-7.76%) on December 31, 2024.
  • During the last 3 years, MLTX annual current assets has risen by +$464.65 million (+4821.69%).
  • MLTX annual current assets is now -7.76% below its all-time high of $514.17 million, reached on December 31, 2023.

Performance

MLTX Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Quarterly Current Assets:

$455.48M-$50.78M(-10.03%)
June 30, 2025

Summary

  • As of today, MLTX quarterly total current assets is $455.48 million, with the most recent change of -$50.78 million (-10.03%) on June 30, 2025.
  • Over the past year, MLTX quarterly current assets has dropped by -$81.40 million (-15.16%).
  • MLTX quarterly current assets is now -17.72% below its all-time high of $553.59 million, reached on March 31, 2024.

Performance

MLTX Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXbalance sheet metrics

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

MLTX Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-7.8%-15.2%
3Y3 Years+4821.7%+363.0%
5Y5 Years+10000.0%+100.0%

MLTX Current Assets Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-7.8%+4821.7%-17.7%+584.9%
5Y5-Year-7.8%>+9999.0%-17.7%>+9999.0%
All-TimeAll-Time-7.8%>+9999.0%-17.7%>+9999.0%

MLTX Current Assets History

DateAnnualQuarterly
Jun 2025
-
$455.48M(-10.0%)
Mar 2025
-
$506.26M(+6.7%)
Dec 2024
$3.64M(-70.5%)
$474.29M(-7.4%)
Sep 2024
-
$512.32M(-4.6%)
Jun 2024
-
$536.88M(-3.0%)
Mar 2024
-
$553.59M(+7.7%)
Dec 2023
$12.37M(+3626.7%)
$514.17M(+2.8%)
Sep 2023
-
$500.01M(-1.3%)
Jun 2023
-
$506.37M(+661.4%)
Mar 2023
-
$66.50M(-13.1%)
DateAnnualQuarterly
Dec 2022
$332.00K(+626.5%)
$76.51M(-13.6%)
Sep 2022
-
$88.54M(-10.0%)
Jun 2022
-
$98.38M(-15.3%)
Mar 2022
-
$116.16M(+1105.4%)
Dec 2021
$45.70K(-100.0%)
$9.64M(+698.5%)
Sep 2021
-
$1.21M(-9.3%)
Jun 2021
-
$1.33M(-8.8%)
Mar 2021
-
$1.46M(-9.8%)
Dec 2020
$115.01M
$1.62M(>+9900.0%)
Sep 2020
-
$0.00

FAQ

  • What is MoonLake Immunotherapeutics annual total current assets?
  • What is the all-time high annual current assets for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual current assets year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly total current assets?
  • What is the all-time high quarterly current assets for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly current assets year-on-year change?

What is MoonLake Immunotherapeutics annual total current assets?

The current annual current assets of MLTX is $474.29M

What is the all-time high annual current assets for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual total current assets is $514.17M

What is MoonLake Immunotherapeutics annual current assets year-on-year change?

Over the past year, MLTX annual total current assets has changed by -$39.88M (-7.76%)

What is MoonLake Immunotherapeutics quarterly total current assets?

The current quarterly current assets of MLTX is $455.48M

What is the all-time high quarterly current assets for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly total current assets is $553.59M

What is MoonLake Immunotherapeutics quarterly current assets year-on-year change?

Over the past year, MLTX quarterly total current assets has changed by -$81.40M (-15.16%)
On this page